Comparative bioavailability of two dexamethasone tablet formulations in Indonesian healthy volunteers

Arzneimittel-Forschung/Drug Research

Volumn 59, Issue 4, 2009, Pages 191-194

  Harahap, Yahdiana ^a   Sasongko, Lucy ^b   Prasaja, Budi ^c   Indriati, Ega ^c   Lusthom, Windy ^c   Lipin, ^c  

^a UNIVERSITY OF INDONESIA   (Indonesia)

^b BANDUNG INSTITUTE OF TECHNOLOGY   (Indonesia)

^c Clinisindo Laboratories   (Indonesia)

Author keywords

CAS 50 02 2; Corticosteroids; Dexamethasone, bioequivalence, pharmacokinetics; Dexmethsone ; Glucocorticoids

Indexed keywords

DEXAMETHASONE; DEXMETHSONE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BIOEQUIVALENCE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIZZINESS; DRUG BIOAVAILABILITY; DRUG ELIMINATION; DRUG HALF LIFE; FEMALE; HEADACHE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN EXPERIMENT; INCREASED APPETITE; INDONESIA; MALE; NAUSEA; NORMAL HUMAN; OPEN STUDY; RANDOMIZED CONTROLLED TRIAL; SINGLE DRUG DOSE; TABLET FORMULATION; VOLUNTEER;

EID: 66149186554     PISSN: 00044172     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0031-1296384     Document Type: Article

References (6)

1. Kim JH, Kim TW, Ryu MH, Chang HM, Lee SH, Lee JS. A randomized crossover study comparing ramosetron plus dexamethasone with ramosetron alone in the prevention of cisplatin-induced emesis. Clin Drug Invest. 2005;25(3):191-197 (Pubitemid 40460645)
2. Henzi I, Walder B, Tramer MR. Dexamethasone for the prevention of postoperative nausea and vomiting: a quantitative systematic review. Anaesth Analg. 2000;90(1):186-194 (Pubitemid 30022994)
3. Lopez-Olaondo L, Carrascosa F, Pueyo FJ, Monedero P, Busto N, Saez A. Combination of ondansetron and dexamethasone in the prophylaxis of postoperative nausea and vomiting. Br J Anaesth. 1996;76:835-840 (Pubitemid 26175638)
4. Czock D, Keller F, Rasche FM, Haussler U. Pharmacokinetics and pharmacodynamics of systemically administered glucocorticoids. Clin Pharmacokinet , 2005;44(1):61-98. (Pubitemid 40096038)
5. CPMP Committee for Propietary Medicinal Products. Note for Guidance on The Investigation of Bioavailability and Bioequivalence (CPMP/EWP/QWP/1401/98). London: EMEA; 2001.
6. Kovarik JM, Purba HS, Pongowski M, Gerbeau C, Humbert H, Mueller EA. Pharmacokinetics of dexamethasone and valspodar, a p-glycoprotein (mdr1) modulator: implications for coadministration. Pharmacotherapy. 1998;18(6):1230-1236 (Pubitemid 28533875)